Literature DB >> 7373219

Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody.

V Schirrmacher, R Cheingsong-Popov, H Arnheiter.   

Abstract

Murine hepatocytes, isolated by an in situ collagenase-perfusion technique and cultured in Petri dishes, were shown to form rosettes with liver-metastasizing syngeneic tumor cells. Pretreatment of the tumor cells with neuraminidase generally increased the binding, whereas pretreatment of the liver cells with neuraminidase abolished the binding completely. The tumor-cell binding may be mediated by the previously described lectin-like receptor of hepatocytes that also was sensitive to neuraminidase treatment and that bound desialylated cells better than normal cells. Anti-H-2 sera could efficiently inhibit the rosette formation of metastatic tumor cells with the hepatocytes, which points to a possible role of H-2 molecules in this interaction of neoplastic and normal cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373219      PMCID: PMC2185824          DOI: 10.1084/jem.151.4.984

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

Authors:  T Kawasaki; G Ashwell
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

2.  The binding of desialylated glycoproteins by plasma membranes of rat liver.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

3.  Virus-induced alterations of lymphoid tissue. IV. The effect of Newcastle disease virus on the fate of transfused thoracic duct lymphocytes.

Authors:  J J Woodruff; J F Woodruff
Journal:  Cell Immunol       Date:  1974-01       Impact factor: 4.868

4.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.

Authors:  V Schirrmacher
Journal:  Int J Cancer       Date:  1979-07-15       Impact factor: 7.396

5.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

Authors:  V Schirrmacher; G Shantz; K Clauer; D Komitowski; H P Zimmermann; M L Lohmann-Matthes
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

6.  Possible mechanism of entrapment of neuraminidase-treated lymphocytes in the liver.

Authors:  H Kolb; A Kriese; V Kolb-Bachofen; H A Kolb
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

7.  Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain.

Authors:  R S Kerbel; R R Twiddy; D M Robertson
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

8.  H-2 restriction of contact inhibition of epithelial cells.

Authors:  A S Curtis; P Rooney
Journal:  Nature       Date:  1979-09-20       Impact factor: 49.962

9.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.

Authors:  V Schirrmacher; K Bosslet; G Shantz; K Clauer; D Hübsch
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

10.  Effect of the H-2 gene complex rates of fibroblast intercellular adhesion.

Authors:  P F Bartlett; M Edidin
Journal:  J Cell Biol       Date:  1978-05       Impact factor: 10.539

View more
  31 in total

Review 1.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

2.  Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan.

Authors:  J Beuth; H L Ko; V Schirrmacher; G Uhlenbruck; G Pulverer
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

3.  Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.

Authors:  M Ferrantini; S Pulciani; E Proietti; G Lespinats; A Anastasi; V Ciolli; P Rizza; F Belardelli
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

4.  Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice.

Authors:  G Pulverer; J Beuth; H L Ko; A Yassin; Y Ohshima; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells.

Authors:  M J Humphries; K Matsumoto; S L White; K Olden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver.

Authors:  G Elia; M Ferrantini; F Belardelli; E Proietti; I Gresser; C Amici; A Benedetto
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

7.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

Review 8.  Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.

Authors:  P De Baetselier; E Roos; L Brys; L Remels; M Gobert; D Dekegel; S Segal; M Feldman
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  A successful liver metastasis model in mice with neuraminidase treated colon 26.

Authors:  K Okuno; Y Shirayama; H Ohnishi; K Yamamoto; M Ozaki; T Hirohata; I Nakajima; M Yasutomi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Liver lectins: mediators for metastases?

Authors:  G Uhlenbruck; J Beuth; V Weidtman
Journal:  Experientia       Date:  1983-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.